ABC
ICPT

Associated Banc-Corp’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Associated Banc-Corp’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22
Closed -$1K – 1062
2020
Q2 		$1K Buy
+22
New +$1.7K ﹤0.01% 912

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Associated Banc-Corp's ICPT Position: Q3 2020 in Review

Associated Banc-Corp sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 22 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in ICPT in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Associated Banc-Corp reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 22 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1K.
  • Associated Banc-Corp first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Associated Banc-Corp's Intercept Pharmaceuticals, Inc. position peaked at $1K in Q2 2020.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Associated Banc-Corp's 13F filing for Q3 2020, filed 12 Nov 2020.